Core-IT Technologies

Core-IT is a South Korean biotechnology company specializing in AI-driven drug discovery and development. The company utilizes its proprietary "Core-IT" platform, which stands for Computational REsearch for Innovative Therapeutics, to identify novel drug targets and optimize lead compounds. By integrating big data, bioinformatics, and artificial intelligence, Core-IT aims to accelerate the development of first-in-class and best-in-class therapies, primarily focusing on oncology and rare diseases. The company leverages network pharmacology to understand complex disease mechanisms and predict drug-target interactions with high precision. Core-IT collaborates with various pharmaceutical partners and academic institutions to validate its computational predictions and advance its internal pipeline toward clinical stages.